← Leaderboards
Jacobo E. Mintzer
Medical University Of South Carolina
$14,580,565
Attributed
$33,821,153
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,821,153 · 8
By mechanism
R01$31,890,030 · 6
T32$1,571,774 · 1
U01$359,349 · 1
Top collaborators
- Krista L. Lanctot12 shared
- Paul B Rosenberg12 shared
- Nathan Herrmann10 shared
- Roberta W Scherer9 shared
- Jane E Joseph5 shared
- Brigid Reynolds4 shared
- Paul S. Aisen1 shared
- Olga Brawman-Mintzer1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Nathan Herrmann$1,621,416
- Andreana Benitez$8,151,805
- Sonja K. Schoenwald$3,671,695
- Dipankar Bandyopadhyay$3,898,094
- Yuko Y Palesch$23,576,921
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCaregiversS DiseaseResponsePlacebosCognitiveAffectDementiaSiteDouble-Blind MethodQuality Of LifeNeuropsychiatryClinical TrialsEquipment And Supply InventoriesCognitive FunctionRandomizedSamplingAdverse EventCooperative StudyImpressionPharmaceutical PreparationsPlacebo Controlled StudySafetyMemory
Grant awards (33)
Lifeâs end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study$2,072,617
R01 · FY2025 · AG · contact PI
LifeâÃÂÃÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$4,560,787
R01 · FY2022 · AG · contact PI
LifeâÃÂÃÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$5,332,036
R01 · FY2021 · AG · contact PI
Using connectomics to characterize risk for Alzheimer's Disease$732,130
R01 · FY2021 · AG
Life's end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial$5,795,813
R01 · FY2020 · AG · contact PI
Using connectomics to characterize risk for Alzheimer's Disease$745,812
R01 · FY2020 · AG
Using connectomics to characterize risk for Alzheimer's Disease$745,812
R01 · FY2019 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,297,999
R01 · FY2018 · AG · contact PI
Using connectomics to characterize risk for Alzheimer's Disease$745,812
R01 · FY2018 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$367,383
R01 · FY2018 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$172,427
R01 · FY2018 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$100,000
R01 · FY2018 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,455,745
R01 · FY2017 · AG · contact PI
Quantitative Neuroimaging Assessment of White Matter Integrity in the Context of Aging and AD$856,753
R01 · FY2017 · AG
Using connectomics to characterize risk for Alzheimer's Disease$745,391
R01 · FY2017 · AG
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$144,804
R01 · FY2017 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,451,083
R01 · FY2016 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$100,000
R01 · FY2016 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,426,649
R01 · FY2015 · AG · contact PI
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)$1,590,989
R01 · FY2014 · AG · contact PI
Apathy in Alzheimer's Disease Methylphenidate Trial$709,569
R01 · FY2010 · AG · contact PI
Apathy in Alzheimer's Disease Methylphenidate Trial$740,419
R01 · FY2009 · AG · contact PI
Institute for Research Minority Training on Mental Health$156,155
T32 · FY2007 · AG · contact PI
Depressoin in Alzheimer's Disease Study-2 (DIADS-2)$69,188
U01 · FY2007 · MH · contact PI
Institute for Research Minority Training on Mental Health$211,627
T32 · FY2006 · AG · contact PI
Depressoin in Alzheimer's Disease Study-2 (DIADS-2)$71,254
U01 · FY2006 · MH · contact PI
Institute for Research Minority Training on Mental Heal*$298,661
T32 · FY2005 · AG
Depressoin in Alzheimer's Disease Study-2 (DIADS-2)$72,969
U01 · FY2005 · MH
Institute for Research Minority Training on Mental Heal*$437,145
T32 · FY2004 · AG
Depressoin in Alzheimer's Disease Study-2 (DIADS-2)$72,969
U01 · FY2004 · MH
Institute for Research Minority Training on Mental Heal*$305,533
T32 · FY2003 · AG
Depressoin in Alzheimer's Disease Study-2 (DIADS-2)$72,969
U01 · FY2003 · MH
Institute for Research Minority Training on Mental Heal*$162,653
T32 · FY2002 · AG